Wendy Klein-Schwartz

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. ncbi Comparison of citalopram and other selective serotonin reuptake inhibitor ingestions in children
    Wendy Klein-Schwartz
    Maryland Poison Center, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA
    Clin Toxicol (Phila) 50:418-23. 2012
  2. ncbi Toxicity of polysaccharide--iron complex exposures reported to poison control centers
    W Klein-Schwartz
    Research and Education, Maryland Poison Center, Baltimore 21201, USA
    Ann Pharmacother 34:165-9. 2000
  3. ncbi Impact of the voluntary withdrawal of over-the-counter cough and cold medications on pediatric ingestions reported to poison centers
    Wendy Klein-Schwartz
    Maryland Poison Center, University of Maryland School of Pharmacy, Baltimore, MD, USA
    Pharmacoepidemiol Drug Saf 19:819-24. 2010
  4. ncbi Prospective observational multi-poison center study of ziprasidone exposures
    Wendy Klein-Schwartz
    Maryland Poison Center, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    Clin Toxicol (Phila) 45:782-6. 2007
  5. ncbi Characterization of gabapentin overdose using a poison center case series
    Wendy Klein-Schwartz
    Maryland Poison Center, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    J Toxicol Clin Toxicol 41:11-5. 2003
  6. ncbi Poison centers' experience with methylphenidate abuse in pre-teens and adolescents
    Wendy Klein-Schwartz
    Maryland Poison Center, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    J Am Acad Child Adolesc Psychiatry 42:288-94. 2003
  7. ncbi Intravenous acetylcysteine for the treatment of acetaminophen overdose
    Wendy Klein-Schwartz
    University of Maryland, School of Pharmacy, 220 Arch Street, Room 01 108, Baltimore, MD 21201, USA
    Expert Opin Pharmacother 12:119-30. 2011
  8. ncbi Abuse and toxicity of methylphenidate
    Wendy Klein-Schwartz
    Research and Education, Maryland Poison Center and Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    Curr Opin Pediatr 14:219-23. 2002
  9. ncbi Trends and toxic effects from pediatric clonidine exposures
    Wendy Klein-Schwartz
    Maryland Poison Center, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, 20 N Pine St, Baltimore, MD 21201, USA
    Arch Pediatr Adolesc Med 156:392-6. 2002
  10. ncbi Frequency of medication errors with intravenous acetylcysteine for acetaminophen overdose
    Bryan D Hayes
    Maryland Poison Center, School of Pharmacy, University of Maryland, Baltimore, MD, USA
    Ann Pharmacother 42:766-70. 2008

Collaborators

Detail Information

Publications41

  1. ncbi Comparison of citalopram and other selective serotonin reuptake inhibitor ingestions in children
    Wendy Klein-Schwartz
    Maryland Poison Center, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA
    Clin Toxicol (Phila) 50:418-23. 2012
    ..Data in children are lacking, yet the 2007 American Association of Poison Control Centers out-of-hospital citalopram consensus guideline mirrors the guideline for other SSRIs...
  2. ncbi Toxicity of polysaccharide--iron complex exposures reported to poison control centers
    W Klein-Schwartz
    Research and Education, Maryland Poison Center, Baltimore 21201, USA
    Ann Pharmacother 34:165-9. 2000
    ..To evaluate the toxicity of polysaccharide-iron complex (PIC) exposures reported to poison centers in the US...
  3. ncbi Impact of the voluntary withdrawal of over-the-counter cough and cold medications on pediatric ingestions reported to poison centers
    Wendy Klein-Schwartz
    Maryland Poison Center, University of Maryland School of Pharmacy, Baltimore, MD, USA
    Pharmacoepidemiol Drug Saf 19:819-24. 2010
    ..To assess the impact of a voluntary withdrawal of over-the-counter cough and cold medications (OTC CCMs) labeled for children under age 2 years on pediatric ingestions reported to the American Association of Poison Control Centers...
  4. ncbi Prospective observational multi-poison center study of ziprasidone exposures
    Wendy Klein-Schwartz
    Maryland Poison Center, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    Clin Toxicol (Phila) 45:782-6. 2007
    ..We characterized the clinical manifestations associated with ziprasidone overdoses, in particular the incidence and severity of QTc prolongation...
  5. ncbi Characterization of gabapentin overdose using a poison center case series
    Wendy Klein-Schwartz
    Maryland Poison Center, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    J Toxicol Clin Toxicol 41:11-5. 2003
    ..Gabapentin is an anticonvulsant that is being used for an increasing number of off-label indications. The purpose of this study is to document the clinical manifestations and outcomes of gabapentin exposures reported to poison centers...
  6. ncbi Poison centers' experience with methylphenidate abuse in pre-teens and adolescents
    Wendy Klein-Schwartz
    Maryland Poison Center, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    J Am Acad Child Adolesc Psychiatry 42:288-94. 2003
    ..To evaluate trends and toxicity of methylphenidate abuse in pre-teens and adolescents reported to poison centers...
  7. ncbi Intravenous acetylcysteine for the treatment of acetaminophen overdose
    Wendy Klein-Schwartz
    University of Maryland, School of Pharmacy, 220 Arch Street, Room 01 108, Baltimore, MD 21201, USA
    Expert Opin Pharmacother 12:119-30. 2011
    ....
  8. ncbi Abuse and toxicity of methylphenidate
    Wendy Klein-Schwartz
    Research and Education, Maryland Poison Center and Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    Curr Opin Pediatr 14:219-23. 2002
    ..Despite its abuse potential, there is disagreement regarding the extent to which methylphenidate is being diverted from legitimate use to abuse in preteens and adolescents...
  9. ncbi Trends and toxic effects from pediatric clonidine exposures
    Wendy Klein-Schwartz
    Maryland Poison Center, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, 20 N Pine St, Baltimore, MD 21201, USA
    Arch Pediatr Adolesc Med 156:392-6. 2002
    ..To analyze the trends, demographics, and toxic effects associated with pediatric clonidine hydrochloride exposures reported to poison centers...
  10. ncbi Frequency of medication errors with intravenous acetylcysteine for acetaminophen overdose
    Bryan D Hayes
    Maryland Poison Center, School of Pharmacy, University of Maryland, Baltimore, MD, USA
    Ann Pharmacother 42:766-70. 2008
    ..The dosing regimen is complex, consisting of a loading dose followed by 2 maintenance doses, each with different infusion rates...
  11. ncbi Unexpected late rise in plasma acetaminophen concentrations with change in risk stratification in acute acetaminophen overdoses
    Patrick P Dougherty
    Clinical Toxicology, University of Maryland School of Pharmacy, Maryland Poison Center, Baltimore, Maryland, USA
    J Emerg Med 43:58-63. 2012
    ..There are case reports of patients with acute overdoses of acetaminophen combination products in whom a toxic PAC occurred later after an initial non-toxic PAC at approximately 4 h...
  12. ncbi Hepatotoxicity despite early administration of intravenous N-acetylcysteine for acute acetaminophen overdose
    Suzanne Doyon
    Maryland Poison Center, University of Maryland School of Pharmacy, Baltimore, MD, USA
    Acad Emerg Med 16:34-9. 2009
    ..The objective was to evaluate the effectiveness of intravenous N-acetylcysteine (IV NAC; 300 mg/kg over 21 hours) in early acute acetaminophen (APAP) overdose patients...
  13. ncbi Comparison of toxicity of acute overdoses with citalopram and escitalopram
    Bryan D Hayes
    Maryland Poison Center, University of Maryland School of Pharmacy, Baltimore, Maryland 21230, USA
    J Emerg Med 39:44-8. 2010
    ..Seizures and QTc prolongation are associated with citalopram poisoning; however, overdose experience with escitalopram is more limited...
  14. ncbi Incidence and onset of delayed seizures after overdoses of extended-release bupropion
    Paul Starr
    Maryland Poison Center Department of Pharmacy Practice and Science, University of Maryland Baltimore, Baltimore, MD 21201, USA
    Am J Emerg Med 27:911-5. 2009
    ..This study systematically evaluates the frequency and timing of seizures and an association between other toxic effects (ie, agitation, tremors, and hallucinations) and seizures...
  15. ncbi Atypical experience: a case series of pediatric aripiprazole exposures
    Amanda L Lofton
    Maryland Poison Center, University of Maryland School of Pharmacy, Baltimore, MD 21201-1180, USA
    Clin Toxicol (Phila) 43:151-3. 2005
    ..Adolescents in this series experienced only minor, if any, clinical effects. Major clinical effects, i.e., seizures, dysrhythmias, were not reported in this series...
  16. ncbi Toxicity of buprenorphine overdoses in children
    Bryan D Hayes
    PharmD, Maryland Poison Center, University of Maryland School of Pharmacy, 220 Arch St, Office Level 1, Baltimore, MD 21201, USA
    Pediatrics 121:e782-6. 2008
    ..The purpose of this study was to analyze buprenorphine overdoses in young children reported by US poison centers to the Researched Abuse, Diversion, and Addiction-Related Surveillance System...
  17. ncbi Evaluation of lamotrigine toxicity reported to poison centers
    Amanda L Lofton
    Maryland Poison Center, School of Pharmacy, University of Maryland, Baltimore, MD, USA
    Ann Pharmacother 38:1811-5. 2004
    ..6%) cases. There were no deaths. CONCLUSIONS: These data demonstrate that the majority of patients exposed to lamotrigine in overdose experienced minor or no clinical effects. Although rare, serious effects can also occur...
  18. ncbi Epidemiology and toxicity of pediatric guanfacine exposures
    Jean C McGrath
    Maryland Poison Center, University of Maryland School of Pharmacy, Baltimore, MD, USA
    Ann Pharmacother 36:1698-703. 2002
    ..To examine the epidemiology and toxicity of guanfacine exposures in children and adolescents reported to poison control centers...
  19. ncbi Octreotide's role in the management of sulfonylurea-induced hypoglycemia
    Patrick P Dougherty
    Maryland Poison Center, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    J Med Toxicol 6:199-206. 2010
    ..Based on animal and human data, there is sufficient evidence to recommend the use of octreotide with supplemental dextrose for the treatment of sulfonylurea-induced hypoglycemia...
  20. ncbi Consistency between coded poison center data and fatality abstract narratives for therapeutic error deaths in older adults
    Bryan D Hayes
    Department of Pharmacy Services, University of Maryland Medical Center, Baltimore, MD, USA
    Clin Toxicol (Phila) 48:68-71. 2010
    ..A secondary goal was to elucidate causes and coding consistency for fatal iatrogenic errors...
  21. ncbi Causes of therapeutic errors in older adults: evaluation of National Poison Center data
    Bryan D Hayes
    Maryland Poison Center, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA
    J Am Geriatr Soc 57:653-8. 2009
    ..To evaluate the reasons for unintentional therapeutic errors in older adults, the types of medications most frequently involved, and the medical outcomes related to these adverse drug events...
  22. ncbi Potential for erroneous interpretation of poisoning outcomes due to changes in National Poison Data System reporting
    Bruce Anderson
    Maryland Poison Center, University of Maryland School of Pharmacy, 220 Arch St, Baltimore, MD 21201, USA
    Clin Toxicol (Phila) 48:745-9. 2010
    ..The objective of this study is to describe the potential impact of this reporting change on longitudinal analysis of outcomes...
  23. ncbi Pediatric methylphenidate exposures: 7-year experience of poison centers in the United States
    Wendy Klein-Schwartz
    Maryland Poison Center, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Clin Pediatr (Phila) 42:159-64. 2003
    ..The trend of increasing frequency of methylphenidate exposures reported to poison centers exactly parallels increasing therapeutic use...
  24. ncbi Acute, unintentional pediatric brodifacoum ingestions
    Greene Shepherd
    Maryland Poison Center, University of Maryland School of Pharmacy, Baltimore, USA
    Pediatr Emerg Care 18:174-8. 2002
    ..Large overdoses and chronic intoxication have been associated with significant coagulopathies and death. Currently, the management of acute unintentional ingestions by young children is controversial...
  25. ncbi A novel approach to informing the public about the risks of overdose and nonmedical use of prescription medications
    Suzanne Doyon
    School of Pharmacy, University of Maryland, Baltimore, MD, USA
    Am J Addict 22:108-12. 2013
    ..Implementation of a telephone-based program of overdose prevention and screening for nonmedical use of prescription medications is examined...
  26. ncbi Decrease in therapeutic errors involving prescription cough and cold medications in young children
    Suzanne Doyon
    University of Maryland School of Pharmacy, Maryland Poison Center, Baltimore, Maryland
    J Pediatr Pharmacol Ther 17:84-7. 2012
    ....
  27. ncbi Polypharmacy and the geriatric patient
    Bryan D Hayes
    Maryland Poison Center, University of Maryland, School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA
    Clin Geriatr Med 23:371-90, vii. 2007
    ..Application of Beers criteria, appropriate therapeutic drug monitoring, and careful, periodic review of the patient's medication list will assist with preventing the sometimes lethal complications of polypharmacy...
  28. ncbi Drug adsorption efficacy and palatability of a novel charcoal cookie formulation
    Wendy Klein-Schwartz
    Maryland Poison Center, Baltimore, Maryland 21201, USA
    Pharmacotherapy 30:888-94. 2010
    ..To determine the effect of a novel charcoal cookie formulation compared with a standard aqueous charcoal product on the absorption of orally administered cimetidine, and to compare the palatability of the two charcoal products...
  29. ncbi Reply to clonidine exposures, not toxicity
    Henry A Spiller
    J Pediatr 149:282-3. 2006
  30. ncbi 2001 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System
    Toby L Litovitz
    Am J Emerg Med 20:391-452. 2002
  31. ncbi Toxic clonidine ingestion in children
    Henry A Spiller
    Kentucky Regional Poison Center, Louisville, Kentucky 40232-5070, USA
    J Pediatr 146:263-6. 2005
    ..1 mg, (2) ingestion of >0.2 mg in children 5 to 8 years of age, and (3) ingestion of >or=0.4 mg in children older than 8 years of age. Observation for 4 hours may be sufficient to detect patients who will develop severe effects...
  32. ncbi 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System
    William A Watson
    Am J Emerg Med 22:335-404. 2004
  33. ncbi 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System
    William A Watson
    American Association of Poison Control Centers, 3201 New Mexico Avenue, Ste. 330, Washington, DC 20016, USA
    Am J Emerg Med 23:589-666. 2005
  34. ncbi Evaluation of toxicity of topiramate exposures reported to poison centers
    A L Lofton
    Beverly Hospital, Northeast Health Systems, USA
    Hum Exp Toxicol 24:591-5. 2005
    ..Serious toxic effects, such as CNS depression with respiratory depression or persistent non-anion gap metabolic acidosis, are infrequent...
  35. ncbi 2005 Annual Report of the American Association of Poison Control Centers' national poisoning and exposure database
    Melisa W Lai
    American Association of Poison Control Centers, Washington, DC, USA
    Clin Toxicol (Phila) 44:803-932. 2006
    ....
  36. ncbi Are 1-2 dangerous? Chloroquine and hydroxychloroquine exposure in toddlers
    E Reed Smith
    Department of Emergency Medicine, George Washington University Medical Center, Washington, DC 20007, USA
    J Emerg Med 28:437-43. 2005
    ..Thus, similar recommendations should be followed for triage after accidental hydroxychloroquine overdose...
  37. ncbi Efficacy of activated charcoal administered more than four hours after acetaminophen overdose
    Henry A Spiller
    Kentucky Regional Poison Center, Louisville, Kentucky 40232-5070, USA
    J Emerg Med 30:1-5. 2006
    ....
  38. ncbi Adverse events associated with dietary supplements: an observational study
    Mary E Palmer
    Department of Emergency Medicine, Landspitali University Hospital, Fossvogi, 108, Reykjavik, Iceland
    Lancet 361:101-6. 2003
    ..Adverse events associated with dietary supplements are difficult to monitor in the USA, because such products are not registered before sale, and there is little information about their content and safety...
  39. ncbi Electrocardiographic changes associated with beta-blocker toxicity
    Jeffrey N Love
    Emergency Department, Georgetown University, Washington, DC, USA
    Ann Emerg Med 40:603-10. 2002
    ..We sought to characterize the ECG changes associated with symptomatic beta-blocker overdose...
  40. ncbi High-dose insulin therapy for calcium-channel blocker overdose
    Greene Shepherd
    College of Pharmacy, University of Georgia, Augusta, GA, USA
    Ann Pharmacother 39:923-30. 2005
    ..To evaluate the evidence for using high-dose insulin therapy with supplemental dextrose and potassium in calcium-channel blocker (CCB) overdose...
  41. ncbi 2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System
    William A Watson
    Am J Emerg Med 21:353-421. 2003